Skip to content

Clinical trials

Cardiovascular Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: Italy Clear all

217 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20042
20052
20063
20074
20089
20098
20108
20118
201211
201310
20142
20158
201611
20175
20187
201914
202010
20217
202211
202319
202422
202516
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed97
Recruiting44
Unknown status35
Active, not recruiting17
Terminated14
Not yet recruiting4
Enrolling by invitation4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
Fondazione Policlinico Universitario Agostino Gemelli IRCCS7
Abbott Medical Devices6
IRCCS San Raffaele6
University of Roma La Sapienza6
Edwards Lifesciences5
IRCCS Azienda Ospedaliero-Universitaria di Bologna5
Istituto Auxologico Italiano5
AstraZeneca4
GlaxoSmithKline4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases217
Heart Diseases35
Diabetes Mellitus, Type 222
Coronary Artery Disease18
Heart Failure17
Hypertension17
Myocardial Infarction17
Vascular Diseases16
Atherosclerosis15
Stroke15

Trials

Showing 51 to 75 of 217. Each trial links to its page on Pharma Observatory.

117 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.